Back to Rankings

ANIK

Anika TherapeuticsA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Above peers
vs peer average
ANIK vs peer average
95/100
ANIK vs. peer average (A vs. D)
Grade spread
B 2 · D 3 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

CDXS is the first available peer comparator.

Same-sector market-cap comparator only; its platform and commercial drivers are not directly comparable to Anika's orthopedic products.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerCDXSCodexis
ANIK
Anika Therapeutics
CDXS
Codexis
Grade
A
F
Momentum
82
10
Value
61
41
Sentiment
54
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs CDXS

ANIK / CDXS
Grade Position
Above peers
ANIK vs. peer average (A vs. D)
95/100
Momentum
82
ANIK
Value
61
ANIK
Sentiment
54
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ANIK
1
CDXS
CDXS
F
20/100
+4
2
DTIL
DTIL
B
80/100
+1
3
IMUX
IMUX
F
20/100
+4
4
NBP
NovaBridge Biosciences ADR
D
40/100
+3
5
NERV
Minerva Neurosciences Inc Common
B
80/100
+1
CDXS is the first peer returned for this comparison set.